|
IMMT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.52430000013959E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.19180000002217E-06 |
| Normal-vs-Stage2 |
1.042200E-02 |
| Normal-vs-Stage3 |
1.602930E-04 |
| Normal-vs-Stage4 |
3.617900E-04 |
| Stage1-vs-Stage2 |
8.545800E-01 |
| Stage1-vs-Stage3 |
8.221000E-01 |
| Stage1-vs-Stage4 |
5.045000E-01 |
| Stage2-vs-Stage3 |
7.517200E-01 |
| Stage2-vs-Stage4 |
5.073400E-01 |
| Stage3-vs-Stage4 |
5.993400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.03019999887178E-08 |
| Normal-vs-AfricanAmerican |
3.444200E-04 |
| Normal-vs-Asian |
4.043400E-01 |
| Caucasian-vs-AfricanAmerican |
2.070800E-01 |
| Caucasian-vs-Asian |
4.242400E-01 |
| AfricanAmerican-vs-Asian |
7.395400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.04539999779396E-08 |
| Normal-vs-Female |
9.378900E-04 |
| Male-vs-Female |
5.067700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.33750000000677E-05 |
| Normal-vs-Extreme_Weight |
8.80820000270788E-08 |
| Normal-vs-Obese |
4.19210000000003E-05 |
| Normal-vs-Extreme_Obese |
5.497000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.352000E-01 |
| Normal_Weight-vs-Obese |
8.126200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.362600E-01 |
| Extreme_Weight-vs-Obese |
3.285400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.498600E-01 |
| Obese-vs-Extreme_Obese |
3.706000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.439500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.13109999980254E-07 |
| Normal-vs-Age(61-80Yrs) |
2.2377999999712E-06 |
| Normal-vs-Age(81-100Yrs) |
4.197900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.864600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.795600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.251800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.403000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.556000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.149800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.69059999999277E-07 |
| Normal-VS-Type2 PRCC |
7.241700E-04 |
| Normal-VS-KIRP CIMP |
3.216000E-04 |
| Normal-VS-Unclassified PRCC |
4.382200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.417790E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.484000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.211400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.675000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.930400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.774600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.39079999994518E-06 |
| Normal-vs-N1 |
9.95840000017623E-07 |
| Normal-vs-N2 |
6.837900E-04 |
| N0-vs-N1 |
7.466000E-01 |
| N0-vs-N2 |
3.903800E-01 |
| N1-vs-N2 |
4.038800E-01 |
|
|
